A Pandemic: 4 in every 10 cats will succumb to a fatal viral disease in their lifetime

If the World Health Organization considers that 0.4% of the human population infected with Covid-19 is a pandemic, then the following viral diseases in cats are true pandemics:

  1. It is estimated that 20% of 200 million owned cats around the world has either Feline Leukemia (FeLV), Feline Immunodeficiency Syndrome (FIV) or both;
  2. It is estimated that another 20% of 200 million owned cats around the world has Feline Infectious Peritonitis (FIP).

This means that 4 in every 10 cats will succumb to one of these fatal diseases in their lifetime. This high prevalence does not include the resurgence of an “old” disease, Feline Panleukopenia (FPV), and an emerging disease, Feline Herpesvirus type-1 (FHV-1).

In dogs, viral diseases are, fortunately, better controlled because of effective vaccines and vaccination programs. Unfortunately, we are seeing a resurgence in canine parvovirosis (CPV-2) and a new strain of canine distemper (CDV), especially in breeding farms and kennels.

Check out on the Communities page to read the experiences of NEW cat owners about RetroMAD1


“In over 100 cases of cats suffering from feline leukemia, presented by their owners from Germany, Malaysia, Singapore, South Africa, and the U.S. that received RetroMAD1TM treatment, the lives of all these cats improved so dramatically that owners could not believe what they witnessed. Without a doubt, RetroMAD1TM saves lives.”

- Dr Cher Yew NG, CEO of Biovalence


RetroMAD1TM - An aid in the fight against medically important viral diseases

With more than 10 years of research and development using a patented recombinant proteomic technology, RetroMAD1 is a fusion of 3 naturally occurring proteins found in plants and animals that have scientifically proven antiviral properties. As an immuno-modulatory supplement, RetroMAD1 is positioned as a supplement of choice for veterinarians and pet owners in their fight against medically important viral diseases. RetroMAD1 can also be deployed as an aid in prophylaxis.

RetroMAD1 comes in an aqueous solution that is stable under ambient temperature for up to 24 months from the date of manufacture. Benefits are:

  1. Easy to administer with high pet and pet owner compliance;
  2. Easy to store and transport;
  3. Designed for community use, e.g. rescue-shelter, multi-pet household.